$WORX
SCWorx Corp. Stock $worx

$worx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072087 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.028M	$986.9K	$1.138M
YoY Change	-17.79%	-13.28%	-2.72%
Cost Of Revenue	$610.0K	$693.4K	$722.0K
YoY Change	-3.15%	-3.97%	-24.79%
Gross Profit	$417.9K	$293.6K	$416.1K
YoY Change	-32.65%	-29.44%	89.13%
Gross Profit Margin	40.65%	29.75%	36.56%
Selling, General & Admin	$675.8K	$832.7K	$1.378M
YoY Change	-54.33%	-39.57%	-38.49%
% of Gross Profit	161.74%	283.62%	331.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$1.350K
YoY Change	-100.0%	-100.0%	-93.25%
% of Gross Profit	0.0%	0.0%	0.32%
Operating Expenses	$675.8K	$1.526M	$1.378M
YoY Change	-54.33%	10.75%	-38.21%
Operating Profit	-$258.0K	-$539.1K	-$961.8K
YoY Change	-69.97%	-43.95%	-52.15%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$139.6K	$0.00
YoY Change			-100.0%
Pretax Income	-$258.0K	-$399.5K	-$961.8K
YoY Change	-69.97%	-58.46%	-65.03%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$258.0K	-$399.5K	-$961.8K
YoY Change	-69.97%	-58.46%	-65.03%
Net Earnings / Revenue	-25.1%	-40.48%	-84.51%
Basic Earnings Per Share		-$0.03	-$0.09
Diluted Earnings Per Share	-$0.02	-$0.03	-$90.27K
COMMON SHARES
Basic Shares Outstanding	13.01M shares	11.74M shares	10.65M shares
Diluted Shares Outstanding		12.07M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$249.5K	$361.7K	$401.6K
YoY Change	250.96%	-9.93%	111.36%
Cash & Equivalents	$249.5K	$361.7K	$401.6K
Short-Term Investments
Other Short-Term Assets	$295.2K	$323.0K	$93.94K
YoY Change	361.65%	243.87%	-63.87%
Inventory			$362.0K
Prepaid Expenses
Receivables	$336.0K	$231.9K	$331.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$880.7K	$916.6K	$1.189M
YoY Change	16.42%	-22.9%	-35.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$2.260K
YoY Change		-100.0%	-97.18%
Goodwill	$8.366M	$8.366M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$8.366M	$8.366M	$8.369M
YoY Change	0.0%	-0.03%	-2.92%
TOTAL ASSETS
Total Short-Term Assets	$880.7K	$916.6K	$1.189M
Total Long-Term Assets	$8.366M	$8.366M	$8.369M
Total Assets	$9.247M	$9.283M	$9.558M
YoY Change	1.36%	-2.87%	-8.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$600.0K	$2.496M
YoY Change	0.0%	-75.96%	-19.74%
Accrued Expenses	$1.364M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.323M	$2.329M	$3.317M
YoY Change	1.69%	-29.78%	-37.05%
LONG-TERM LIABILITIES
Long-Term Debt	$147.8K	$154.4K	$433.6K
YoY Change	-65.92%	-64.39%	49.51%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$147.7K	$154.4K	$433.6K
YoY Change	-65.92%	-64.39%	49.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.323M	$2.329M	$3.317M
Total Long-Term Liabilities	$147.7K	$154.4K	$433.6K
Total Liabilities	$2.471M	$2.484M	$3.751M
YoY Change	-9.1%	-33.79%	-32.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.86M	-$25.60M
YoY Change	7.69%
Common Stock	$13.01K	$13.01K
YoY Change	15.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.777M	$6.799M	$5.807M
YoY Change
Total Liabilities & Shareholders Equity	$9.247M	$9.283M	$9.558M
YoY Change	1.36%	-2.87%	-8.71%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$258.0K	-$399.5K	-$961.8K
YoY Change	-69.97%	-58.46%	-65.03%
Depreciation, Depletion And Amortization	$0.00	$0.00	$1.350K
YoY Change	-100.0%	-100.0%	-93.25%
Cash From Operating Activities	-$112.3K	-$386.8K	-$255.5K
YoY Change	-66.04%	51.41%	82.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$525.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	725.1K	625.0K
YoY Change		16.01%
NET CHANGE
Cash From Operating Activities	-112.3K	-386.8K	-255.5K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	0.000	725.1K	625.0K
Net Change In Cash	-112.3K	338.2K	369.5K
YoY Change	-66.04%	-8.47%	-363.94%
FREE CASH FLOW
Cash From Operating Activities	-$112.3K	-$386.8K	-$255.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10267543	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10654635	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11616820	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12069412	shares
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13010409	shares
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37899
	dei	Entity Registrant Name EntityRegistrantName	SCWORX CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5412331
	dei	Entity Address Address Line1 EntityAddressAddressLine1	590 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	21st Floor
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(844)
	dei	Local Phone Number LocalPhoneNumber	472-9679
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	WORX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361726	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71075	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	231886	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	464851	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	156600	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	323028	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	63942	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	916640	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	756468	usd
CY2022Q3	us-gaap	Goodwill Goodwill	8366467	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8366467	usd
CY2022Q3	us-gaap	Assets Assets	9283107	usd
CY2021Q4	us-gaap	Assets Assets	9122935	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1651912	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1432710	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	153838	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	153838	usd
CY2022Q3	worx	Shareholder Advance ShareholderAdvance	100000	usd
CY2021Q4	worx	Shareholder Advance ShareholderAdvance	100000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	298500	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	472750	usd
CY2022Q3	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2021Q4	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2329250	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2284298	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	154376	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	433567	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	154376	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	433567	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2483626	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2717865	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13007409	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13007409	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11293030	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11293030	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	13008	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	11293	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31787156	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29805028	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	600000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	600000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25600723	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24011291	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6799481	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6405070	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9283107	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9122935	usd
CY2022Q3	us-gaap	Revenues Revenues	986949	usd
CY2021Q3	us-gaap	Revenues Revenues	1138124	usd
	us-gaap	Revenues Revenues	3010322	usd
	us-gaap	Revenues Revenues	3382205	usd
CY2022Q3	worx	Cost Of Revenues CostOfRevenues	693353	usd
CY2021Q3	worx	Cost Of Revenues CostOfRevenues	722031	usd
	worx	Cost Of Revenues CostOfRevenues	2014537	usd
	worx	Cost Of Revenues CostOfRevenues	2152651	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	832715	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1377900	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2864408	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4184848	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1526068	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2099931	usd
	us-gaap	Operating Expenses OperatingExpenses	4878945	usd
	us-gaap	Operating Expenses OperatingExpenses	6337499	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-539119	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-961807	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1868623	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2955294	usd
CY2022Q3	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	139596	usd
	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	279191	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139596	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	279191	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-399523	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-961807	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1589432	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2955294	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-399523	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-961807	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1589432	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2955294	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12069412	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10654635	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11616820	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10267543	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	66874	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	725050	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	261370	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-399523	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6799481	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6405070	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	151874	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	725050	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise One CommitmentSharesIssuedInConjunctionWithCapitalRaiseOne	200000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	906919	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1589432	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	6799481	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5353448	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	191078	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	525000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	699084	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-961807	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	5806803	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5734016	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	323635	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	525000	usd
	worx	Shares Issued For Equity Financing SharesIssuedForEquityFinancing	250000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1929446	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2955294	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	5806803	usd
	us-gaap	Profit Loss ProfitLoss	-1589432	usd
	us-gaap	Profit Loss ProfitLoss	-2955294	usd
	us-gaap	Depreciation Depreciation	73901	usd
	worx	Change In Inventory Value ChangeInInventoryValue	156600	usd
	worx	Change In Inventory Value ChangeInInventoryValue	161440	usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	279191	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	906919	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1929446	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	78125	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	125625	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-154840	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-265106	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	59086	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6312	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-475000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	371076	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-241840	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-174250	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-566500	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-434399	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-739428	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	725050	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	525000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	139595	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	725050	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	764595	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	290651	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25167	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71075	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376425	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361726	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	401592	usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings	250000	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise CommitmentSharesIssuedInConjunctionWithCapitalRaise	200000	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	108	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	505	usd
CY2022Q3	worx	Acquired Technology Predecessor Cost AcquiredTechnologyPredecessorCost	0	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	111726	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	523440	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	156600	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit and Other Risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, accounts receivable and warrants. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing internal credit evaluations of its customers’ financial condition, obtains deposits and limits the amount of credit extended when deemed necessary but generally requires no collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant customers are those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total net accounts receivable are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Revenue <br/> For the nine months ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accounts Receivable<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="text-decoration:underline">Customers</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	421736	usd
CY2021Q4	worx	Gowns In Inventory GownsInInventory	87000	usd
CY2021Q4	us-gaap	Other Inventory OtherInventory	366840	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	523440	usd
CY2022Q3	worx	Allowance For Obsolescence AllowanceForObsolescence	523440	usd
CY2021Q4	worx	Allowance For Obsolescence AllowanceForObsolescence	366840	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1353	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73901	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	298500	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	472750	usd
CY2022Q3	worx	Contract Liabilities ContractLiabilities	298500	usd
CY2021Q4	worx	Contract Liabilities ContractLiabilities	472750	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2022Q3	worx	Operating Lease Liabilities OperatingLeaseLiabilities	0	usd
	us-gaap	Interest Paid InterestPaid		usd
CY2021Q4	worx	Operating Lease Liabilities OperatingLeaseLiabilities	0	usd
CY2022Q1	worx	Shares Issued As Settlement Of Accounts Payable1 SharesIssuedAsSettlementOfAccountsPayable1	12196	usd
CY2022Q1	worx	Accounts Payable Current1 AccountsPayableCurrent1	10000	usd
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.82
	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
CY2022Q3	worx	Operating Leases Cost OperatingLeasesCost	434	usd
CY2021Q3	worx	Operating Leases Cost OperatingLeasesCost	1167	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to the allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Actual results could differ materially from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3	worx	Shares Issued As Settlement Of Accounts Payable1 SharesIssuedAsSettlementOfAccountsPayable1	69444	usd
CY2022Q3	worx	Accounts Payable Current1 AccountsPayableCurrent1	50000	usd
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.72
	us-gaap	Depreciation Depreciation		usd
CY2020Q2	worx	Cares Act Description CARESActDescription	The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed under the CARES Act and used for payroll costs, rent, mortgage interest, and utility costs during the 24 week period after the date of loan disbursement is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. While the full loan amount may be forgiven, the amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels or less than 60% of the loan proceeds are used for payroll costs.
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-03-05
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	139569	usd
CY2021Q1	worx	Finance Leases Liability FinanceLeasesLiability	139595	usd
	worx	Operating Leases Cost OperatingLeasesCost	921	usd
	worx	Operating Leases Cost OperatingLeasesCost	17697	usd
CY2022Q3	worx	Total Leases Cost TotalLeasesCost	434	usd
CY2021Q3	worx	Total Leases Cost TotalLeasesCost	1167	usd
	worx	Total Leases Cost TotalLeasesCost	921	usd
	worx	Total Leases Cost TotalLeasesCost	17697	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	434	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	921	usd
CY2022Q1	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	Under the terms of this agreement, (i) the insurers for the Company and Marc Schessel (former CEO) will make a cash payment to the class plaintiffs (ii) the former CEO will transfer 100,000 shares of company common stock to the class plaintiffs, and (iii) the Company will issue $600,000 worth of common stock to the class plaintiffs, in exchange for which all parties will be released from all claims related to the securities class action litigation. After giving effect to the share issuance by the Company, the Company believes that it will have satisfied the accrued retention liability of $700,000.
CY2022Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	190000	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	500000	usd
CY2022Q2	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	on or about April 6, 2022, the Company reached a settlement in principle with the SEC Staff which, subject to a few changes, was subsequently approved by the Commission in which the Company agreed to resolve the SEC’s investigation regarding the April 13, 2020 press release and related disclosures (related to Covid-19 rapid test kits) through the Company’s payment of (a) a civil monetary penalty of $125,000, payable in 4 equal installments over 12 months and (b) disgorgement of $471,000 and prejudgment interest in the amount of $32,761.56 which payment is to be deemed satisfied by the transfer by the Company, no later than 30 days after the entry of the Class Distribution Order in the class action entitled Yannes v. SCWorx Corp. of shares of SCWorx’s common stock, valued at $600,000 at the time of issuance to authorized claimants in the Yannes settlement, provided that the Class Distribution Order is entered within 365 days from the entry of the Final Judgment in the SEC action. In the event that the Company does not transfer shares of its common stock, valued at $600,000 at the time of issuance to authorized claimants in the class action settlement within 365 days from the entry of a Final Judgment, the Company will be required to remit to the SEC the full amount of disgorgement within 395 days from entry of a Final Judgment. On May 31, 2022, the Commission filed a complaint against Marc Schessel and the Company in the United States District Court for the District of New Jersey alleging violations of Sections 17(a)(1), 17(a)(2), and 17(a)(3) of the Securities Act of 1933 (the “Securities Act”), Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), and Rules 10b-5(a), 10b-5(b), and 10b-5(c) thereunder relating to the April 13, 2020 press release and related disclosures we made in relation to the transaction involving COVID-19 test kits. At the same time, on May 31, 2022, the Commission filed a motion for approval of the Consent Judgment which contained the aforementioned fine, disgorgement requirement as well as an agreement by the Company to an injunction permanently restraining and enjoining the Company from violating Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) [15 U.S.C. § 78j(b)] and Rules 10b-5(a), (b), and (c) thereunder [17 C.F.R § 240.10b .. 5(a), (b), (c)]; and Section 17(a) of the Securities Act of 1933 (“Securities Act’’) [15 U.S.C. § 77q(a)]. On June 2, 2022, the Court granted the motion, approved the settlement and entered a final judgment. SCWorx has thus far paid 2 of 4 installments on the monetary penalty of $125,000.
CY2022Q1	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	107998	shares
CY2022Q3	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	107998	shares
CY2022Q3	worx	Shares Issued As Settlement Of Accounts Payable1 SharesIssuedAsSettlementOfAccountsPayable1	21360	usd
CY2022Q3	worx	Accounts Payable Current1 AccountsPayableCurrent1	16875	usd
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.79
CY2022Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	75000	usd
CY2022Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	75000	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	277778	shares
CY2022Q2	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	200000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.72
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1153845	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1153845	shares
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	750000	usd
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.65
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	725050	usd
CY2020Q2	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	During May 2020, the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of September 30, 2022, $415,000 worth of the shares and warrants have been issued.
CY2022Q3	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	551000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	1000000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	261370	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	699084	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	906919	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1929446	usd
CY2022Q3	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	261370	usd
CY2021Q3	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	699084	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	906919	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	1929446	usd
CY2022Q3	worx	Share Based Compensation Total ShareBasedCompensationTotal	261370	usd
CY2021Q3	worx	Share Based Compensation Total ShareBasedCompensationTotal	699084	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	906919	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	1929446	usd
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4098867	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3486831	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4098867	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3486831	shares
CY2022Q3	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	153838	usd
CY2021Q4	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	153838	usd
CY2021Q3	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	100000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q3	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
CY2021Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities		usd
CY2021Q3	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities		usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings		usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise CommitmentSharesIssuedInConjunctionWithCapitalRaise		usd
CY2022Q3	us-gaap	Inventory Net InventoryNet		usd
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount		usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001674227

Files In Submission

Name	View Source	Status
0001213900-22-072087-index-headers.html	Edgar Link	pending
0001213900-22-072087-index.html	Edgar Link	pending
0001213900-22-072087.txt	Edgar Link	pending
0001213900-22-072087-xbrl.zip	Edgar Link	pending
f10q0922ex10-1_scworxcorp.htm	Edgar Link	pending
f10q0922ex31-1_scworxcorp.htm	Edgar Link	pending
f10q0922ex31-2_scworxcorp.htm	Edgar Link	pending
f10q0922ex32-1_scworxcorp.htm	Edgar Link	pending
f10q0922ex32-2_scworxcorp.htm	Edgar Link	pending
f10q0922_scworxcorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
f10q0922_scworxcorp_htm.xml	Edgar Link	completed
worx-20220930.xsd	Edgar Link	pending
worx-20220930_def.xml	Edgar Link	unprocessable
worx-20220930_cal.xml	Edgar Link	unprocessable
worx-20220930_lab.xml	Edgar Link	unprocessable
worx-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WORX
SCWorx Corp. Stock $worx

2022 Q4 Form 10-Q Financial Statement

#000121390022072087 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX SCWorx Corp. Stock $worx

2022 Q4 Form 10-Q Financial Statement

#000121390022072087 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX
SCWorx Corp. Stock $worx